Generic drug manufacturers are the primary manufacturers in the pharmaceutical industry. As I said, more than 11,000 people develop and manufacture products in Canada and export them to over 100 countries.
With a 12-year extension of the patent, the challenges will be greater than they are now. Therefore, the export provision is very important. During the extension period, companies in Canada can start manufacturing products and exporting them to countries where the patent has already expired.